The global microdeletion probes market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The growing research related to genomic DNA sequences coupled with the advancements in the biotechnology field has paved numerous opportunities for market growth. Microdeletions are considered to have a critical role in the occurrence, which results in the demand for the diagnosis of genetic disorders and cancer. These genetic diseases majorly include acute lymphoblastic leukaemia, Prader-Willi syndrome, Angelman syndrome, Down’s syndrome, chronic myelogenous leukaemia, Velocardiofacial syndrome, 22q13 deletion syndrome, and cri-du-chat. The rising incidences of these diseases are anticipated to create the demand for an effective diagnostic solution such as microdeletion probes. As per the Centers for Disease Control and Prevention (CDC) in 2018, Down’s syndrome was the most common genetic disorder with almost one in every 700 new newborns affected by the disorder. 

These diseases can be diagnosed using microdeletion probes which can detect deletions or duplications in genomic DNA sequences. Microdeletion probes are primarily utilized for microarray studies, which enables the identification of genes in charge of human genetic disorders. These defects occur due to either missing or extra copy number regions in a specific region of a chromosome resulting in various diseases including cancers and autoimmune diseases. Microarray analysis provides information regarding gene expression pattern changes related to deletion or duplication of specific regions. Microdeletion probes are nucleic acid sequences ranging from 15 to 100 bases in length, which can detect deletions or duplications in genomic DNA sequences by acting as substrates for polymerase chain reaction (PCR) and fluorescence resonance energy transfer (FRET). Furthermore, some key players operating in the market include Abbott Laboratories, Creative Bioarray, Empire Genomics, and Leica Biosystems, among others. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Abbott Laboratories, Creative Bioarray, Empire Genomics, and Leica Biosystems, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Microdeletion Probes Market by Segment

By Type 

• Dual Color

• Multi-color 

By Application 

• Cancer

• Autoimmune Diseases

• Others

Global Microdeletion Probes Market by Region